Email Address / User Name:
:Remember Login

Register Here!

Our Services

Naked Short List

by Date

by Exchange

Our Press Releases

SEC & Other Articles

Symbol :

Listed 4 Consecutive Market Days. On List as of 01/25/2012 Through 01/31/2012

Current Quote*

Last: $0.000
Volume: 0

As Of: 2014-04-23 13:45:26 ET
*Quotes delayed by 20min.

BioSante Pharmaceuticals Inc (NASDAQ:BPAX)
Industry: Healthcare

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of various products for female sexual health and oncology. It provides LibiGel, a transdermal testosterone gel that is in Phase III clinical development for the treatment of female sexual dysfunction; and male testosterone gel for the treatment of hypogonadism in men, which is licensed to Teva Pharmaceuticals USA, Inc. The company also offers various cancer vaccines, which are in Phase I and Phase II clinical trials for the treatment of melanoma, leukemia, pancreatic, breast, and prostate cancer; The Pill-Plus, which is in Phase II clinical trials is a combination of estrogens, progestogens, and androgens to prevent testosterone deficiency; and Elestrin, a food and drug administration approved product for the treatment of hot flashes associated with menopause. BioSante Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Lincolnshire, Illinois.

Realtime Data

BuyIns.Net Releases for Symbol BPAX

3 Month

6 Month

1 Year